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INTRODUCTION
Borderline ovarian tumors constitute about 4-14% of all 
ovarian cancers. In contrast, fallopian tubal or paratubal bor-
derline tumors are extremely rare and have not been well de-
fined [1,2]. To our knowledge, only 10 cases of fallopian tubal 
serous borderline tumors have been described since 1965. In 
addition, only one case of paratubal serous borderline tumor 
has been reported in the literature [2], although paratubal 
cysts are common incidental findings during gynecologic 
operations [3]. Therefore, the clinicopathologic characteristics 
and treatments of these tumors are unclear. We describe here 
a patient with a paratubal serous borderline tumor, which 
should be differentiated from an ovarian or fallopian tubal se-
rous borderline tumor, along with a review of the literature.
CASE REPORT
A 27-year-old, nulliparous (0-0-0-0), married woman was re-
ferred to our institution with a huge pelvic mass and left flank 
pain. She had no history of surgical or medical disease. Trans-
vaginal ultrasonography revealed a 16 cm right adnexal cyst 
with intramural nodules and thickened cyst wall (Fig. 1). Ab-
domino-pelvic computed tomography (CT) scan showed a 16 
cm cystic mass with enhancing solid intramural nodules in the 
pelvic cavity (Fig. 1). The CT scan showed no evidence of asci-
tes, peritoneal seeding, omental cake, or pelvic or para-aortic 
lymph node involvement. It looked like an epithelial ovarian 
cancer because the CT scan showed delayed enhancement. 
Her serum cancer antigen 125 (CA-125) concentration was 
19.3 U/mL (reference value, <35 U/mL), and the results of 
other preoperative work-up tests were unremarkable. 
We performed an exploratory laparotomy through a low 
midline abdominal incision, which revealed a 16 cm right 
paratubal cyst completely differentiated from the right ovary 
and fallopian tube. Paratubal cystectomy was performed 
without rupture of the cyst. Frozen section analysis of the 
specimen showed that it was a paratubal serous borderline 
tumor. Exploration of the entire peritoneal cavity showed no 
Case Report
Paratubal serous borderline tumor
You-Jung Shin
1, Ji-Young Kim
1, Hee Jin Lee
2, Jeong-Yeol Park
1, Joo-Hyun Nam
1
Departments of 
1Obstetrics and Gynecology and 
2Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 
Korea
Received Jul 17, 2010, Revised Sep 27, 2010, Accepted Oct 14, 2010
Correspondence to Jeong-Yeol Park
Department of Obstetrics and Gynecology, Asan Medical Center, University 
of Ulsan College of Medicine, 388-1 Pungnap 2-dong, Songpa-gu, Seoul 
138-736, Korea. Tel: 82-2-3010-3646, Fax: 82-2-477-7331, E-mail: catgut1-0@
hanmail.net
pISSN 2005-0380 
eISSN 2005-0399
Copyright © 2011. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology 
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and 
reproduction in any medium, provided the original work is properly cited.
www.ejgo.org
Although paratubal cysts are well-characterized incidental findings, paratubal serous borderline tumors are very rare, with only 
one case report in the literature. We describe here a 27-year-old, nulliparous, married woman with a paratubal serous borderline 
tumor. The patient presented with a huge pelvic mass accompanied by flank pain and underwent paratubal cystectomy and 
fertility-sparing surgical staging procedures. Thirteen months after surgery, she delivered a healthy baby at term. She is well, 
without evidence of disease, 20 months after surgery. Because paratubal serous borderline tumors are very rare, their optimal 
management must be extrapolated from their ovarian counterparts.
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evidence of intraperitoneal tumor spread. Her fallopian tubes, 
ovaries and uterus were not involved. Washing cytology and 
multiple peritoneal biopsies were taken. Because the patient 
and her husband had a strong desire to preserve fertility, her 
uterus and both adnexae were preserved. 
Grossly, the tumor had a homogeneous, purplish white in-
ner surface and multiple papillary projections up to 2.1 cm in 
greatest dimension (Fig. 2). The external surface of the tumor 
was homogeneously purplish white and smooth, with multi-
focal hemorrhage. However, there was no evidence of surface 
involvement. The final pathology results were identical to the 
frozen biopsy results indicating that the mass was a paratubal 
serous borderline tumor (Fig. 2). The results of the peritoneal 
washing cytology and multiple biopsies were negative.
Her postoperative course was uneventful and she was dis-
charged 5 days after surgery. Regular check-ups at the outpa-
tient clinic include serum CA-125 measurements, transvaginal 
ultrasonography, and/or abdomino-pelvic CT. She delivered a 
healthy baby at term 13 months after surgery. Twenty months 
after surgery, she is doing well, without evidence of disease. 
DISCUSSION
Paratubal cysts, also known as hydatid cysts of Morgagni, 
are common incidental findings during surgery or autopsy 
[3]. These small round cysts are attached by a pedicle to the 
fimbriated end of the fallopian tube. Paratubal cysts are of 
paramesonephric (müllerian) origin and are lined by a single 
tubal-type ciliated epithelium [3]. Most paratubal cysts are 
unilateral, asymptomatic and benign, but they may occasion-
ally give rise to clinical problems due to enlargement or tor-
sion. Paratubal serous borderline tumors are very rare, with 
only one previous case report in a 26 year-old woman who 
presented with torsion of the cyst [2]. This patient was suc-
cessfully managed with right salpingo-oophorectomy and 
fertility-sparing comprehensive surgical staging procedures 
[2]. Our patient underwent a paratubal cystectomy and fertil-
ity-sparing comprehensive surgical staging procedures. After 
surgery, she achieved a successful pregnancy and delivered a 
normal healthy baby. 
Borderline tumors, also called tumors of low malignant po-
tential, are characterized pathologically by features of malig-
Fig. 1. Transvaginal ultrasonography 
(A) and abdomino-pelvic computed 
tomography (B) showing a 16 cm cystic 
mass with enhancing intramural solid 
nodules (arrows) in the pelvic cavity.
Fig. 2. (A) Grossly, the tumor had a homogeneous purplish white inner surface and multiple yellow papillary projections up to 2.1 cm in 
greatest dimension. (B, C) Microscopic finding of paratubal serous borderline tumor: epithelial cells with mild nuclear atypia show stratification 
and appear to be free-floating around the smaller papillae (B, C: H&E, x400).Paratubal serous borderline tumor
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nant tumors, including cellular proliferation, stratification of 
the epithelial lining of the papillae, nuclear atypia, and elevat-
ed mitotic activity, but without destructive stromal invasion 
[2]. Borderline epithelial ovarian tumors are not uncommon 
and have been well characterized. In contrast, fallopian tubal 
and paratubal borderline tumors are much rarer and therefore 
not well defined. To our knowledge, only 11 cases of serous 
borderline tumors of the fallopian tube and paratubal cyst 
have been reported in the English language literature [1,2,4-
12]. The clinico-pathologic features of these patients, as well 
as of the patient described here, are summarized in Table 
1 [1,2,4-12]. The patient’s age ranged from 19 to 47 years, 
with a mean age of about 31 years. Most tumors occurred in 
young women, although a few occurred in postmenopausal 
women. Seven of the 13 women presented with abdominal 
pain, whereas the others had asymptomatic masses that were 
discovered during routine pelvic examination. Two patients 
showed elevated serum CA-125, as high as 108 and 43.6 U/
mL, respectively [7,10]. All tumors were unilateral, measuring 
1.7 to 16 cm in diameter, with the largest to date in the pa-
tient described here (16 cm right paratubal cyst). None of the 
patients showed evidence of peritoneal seeding. Nine of the 
13 patients underwent conservative surgery. None of the 13 
had metastasis or recurrence after follow-up periods of 11-72 
months. Two patients, including the one described here, suc-
cessfully delivered healthy babies at term [6]. 
Because fallopian tubal and paratubal borderline tumors are 
very rare, optimal management of patients with these tumors 
must be extrapolated from their ovarian counterparts [2,10]. 
Since most of these tumors are unilateral and confined to the 
fallopian tube or paratubal cyst and since most patients are 
young, fertility-sparing surgery with comprehensive surgical 
staging procedures is acceptable, and adjuvant chemotherapy 
is likely unnecessary. Acceptable fertility-sparing procedures 
for young patients who desire to maintain childbearing po-
tential include salpingectomy for fallopian tubal serous bor-
derline tumors and paratubal cystectomy for paratubal serous 
borderline tumors. 
Table 1. Serous borderline tumors of the fallopian tube and paratubal cyst: clinical and pathological features of 12 cases
Author Age 
(yr)
Tumor 
type Presentation Surgery Size 
(cm) Follow-up
Fallopian tube
Gatto (1986) [4] 19 Serous Pelvic pain, cul-de-sac mass Partial salpingectomy  4 18 mo, DF
Valerdiz Casasola 
(1989) [5]
32 Serous IF during an early pregnancy Salpingectomy 2.5 DF after unspecified 
time
Zheng (1996) [6] 31 Serous Pelvic pain, CA-125=108 U/mL Left SO, right ovarian biopsy, pelvic 
no  de sampling, washings, PO, 
appen  dectomy
6 72 mo DF
Alvarado-Cabrero 
(1997) [7]
34 Serous IF during elective surgery NR 1.7 29 mo DF
Kayaalp (2000) [8] 31 Serous Adnexal mass on routine exam Right salpingectomy 13 NR
Haratz-Rubenstein 
(2004) [9]
28 Serous Pelvic pain, CA-125 =35 U/mL Left salpingectomy 5 NR
Krasevic (2005) [10] 34 Serous Adnexal mass routine exam Right salpingectomy 4.4 55 mo DF
Villella (2005) [1] 22 Serous Pelvic pain Partial salpingectomy, tubal 
cystectomy
3.4 36 mo DF
43 Serous Fibroid uterus TAH, BSO, 2nd staging surgery 5 NR
Park (2009) [11] 47 Serous IF during Laparoscopic hysterec-
tomy for increasing myoma
TAH, BSO, PLND, PALND total  
omen  tec  tomy appendectomy
2 NR
Abreu (2010) [12] 25 Serous Pelvic pain, adnexal mass,  
CA-125=43.6 U/mL
SO, PO, peritoneal biopsy 5 4 yr DF
Paratubal cyst
Seamon (2008) [2] 26 Serous Pelvic pain, pelvic mass, torsion Right SO, PO, PPALND, peritoneal 
bio  psy, appendectomy 
12.5 11 mo DF
Current case (2010) 27 Serous Left flank pain, pelvic mass Right paratubal cystectomy,  
wa  shings, peritoneal biopsy
16 20 mo DF
DF, disease free; IF, incidental finding; SO, salpingo-oophorectomy; NR, not reported; TAH, total abdominal hysterectomy; BSO, bilateral SO; PO, 
partial omentectomy; LND, lymph node dissection; PLND, pelvic LND; PALND, para-aortic LND; PPALND, pelvic and para-aortic LND.You-Jung Shin, et al.
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